[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338506-105":59,"doc-detail-338506-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","tumor-associated-macrophages-in-bladder-cancer-roles-and-targeted-therapeutic-strategies","Tumor-associated macrophages in bladder cancer - roles and targeted therapeutic strategies","","Tumor-associated macrophages (TAMs) are prominent infiltrating immune cells in bladder cancer (BC) and influence disease development, progression, and patient outcomes. Despite limited bladder-specific evidence compared with other cancers, TAM targeting has shown promising clinical-trial results elsewhere and motivates further therapeutic development. This review details how TAMs relate to BC staging, evolutionary dynamics, prognosis, and treatment response, and highlights potential TAM-related targets to suppress tumor-promoting macrophage programs and improve outcomes in advanced BC.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/tumor-associated-macrophages-in-bladder-cancer-roles-and-targeted-therapeutic-strategies/338506/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/tumor-associated-macrophages-in-bladder-cancer-roles-and-targeted-therapeutic-strategies/338506.png","ImageObject",300,407,{"name":92,"@type":93},"Evangeline","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why are tumor-associated macrophages important in bladder cancer?","Question",{"text":113,"@type":114},"TAMs are abundant infiltrating immune cells in the bladder cancer tumor microenvironment. They affect disease development, progression, treatment response, and metastasis through immunomodulatory factors and angiogenesis.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What is the current clinical situation for advanced bladder cancer?",{"text":118,"@type":114},"Even with chemotherapy, immunotherapy, and surgery, overall survival for advanced bladder cancer remains low. Intravesical BCG and other regimens still leave a substantial recurrence risk and some patients progress to muscle-invasive or metastatic disease.",{"name":120,"@type":111,"acceptedAnswer":121},"How do TAMs arise in the bladder cancer tumor microenvironment?",{"text":122,"@type":114},"TAMs originate from bone-marrow-derived monocytes recruited by chemokines, and they can also differentiate from tissue-resident macrophages in response to tumor-related and microenvironment injury factors.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},338506,1790126573,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},13056703019662,"https://ap-avatar.wpscdn.com/avatar/be000253a8e92610077?_k=1778726343310543188","TYPE Review  \nPUBLISHED 13 November 2024 DOI 10.3389/fimmu.2024.1418131  \nOPEN ACCESS  \nEDITED BY  \nAlejandro Villagra,  \nGeorgetown University, United States  \nREVIEWED BY  \nHaitao Wang,  \nNational Cancer Institute (NIH), United States Wenshen Wang,  \nJohns Hopkins University, United States Pengyu Guo,  \nHarbin Medical University Cancer Hospital, China  \n*CORRESPONDENCE  \nRong Yang  \n [doctoryr@gmail.com](doctoryr@gmail.com)[ ](doctoryr@gmail.com)Hongqian Guo  \n [dr.ghq@nju.edu.cn](dr.ghq@nju.edu.cn)  \n†These authors have contributed equally to this work  \nRECEIVED 16 April 2024  \nACCEPTED 25 October 2024  \nPUBLISHED 13 November 2024  \nCITATION  \nMa Y, Sun Y, Guo H and Yang R (2024) Tumor-associated macrophages in bladder cancer: roles and targeted therapeutic strategies.  \nFront. Immunol. 15:1418131 .  \ndoi: 10.3389/fimmu.2024.1418131  \nCOPYRIGHT  \n© 2024 Ma, Sun, Guo and Yang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nTumor-associated macrophages in bladder cancer: roles and targeted therapeutic strategies  \nYuanchun Ma 1†, Ying Sun 1,2†, Hongqian Guo 1* and Rong Yang 1*  \n1 Department of Urology, Nanjing Drum Tower Hospital, Afﬁliated Hospital of Medical School, Nanjing University, Nanjing, China, 2 Department of Urology, Nanjing Drum Tower Hospital, Nanjing Drum Tower Hospital Center of Molecular Diagnostic and Therapy, State Key Laboratory of Pharmaceutical Biotechnology, Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, Nanjing University Advanced Institute of Life Sciences (NAILS), Nanjing, China  \nBladder cancer (BC) is the ninth most common and “expensive” cancer in the world. Despite the availability of various treatment modalities such as chemotherapy, immunotherapy and surgery, the overall survival rate of patients with advanced bladder cancer remains low. As one of the most abundant inﬁltrating immune cells in bladder cancer, tumor-associated macrophages (TAMs) play an important role in the development of BC and in the standard regimen of intravesical BCG therapy. Targeting TAMs have achieved excellent results in clinical trials for a variety of other cancers, but few studies have been conducted for bladder cancer. Further exploration is still needed to develop TAM-related therapeutic strategies for BC treatment, which are expected to improve the therapeutic efﬁcacy and life quality of patients. This review summarizes the relationship between TAMs in bladder cancer and disease staging, evolution, patient prognosis, and treatment outcome. Several potential TAM targets in BC are also pointed, which may help to inhibit tumor-promoting TAMs and provide new therapeutic approaches for advanced BC.  \nKEYWORDS  \ntumor-associated macrophage, tumor immune microenvironment, macrophage targeted therapy, bladder cancer, macrophage polarization  \n1 Introduction  \nBladder cancer is the ninth most common cancer in the world and one of the most common genitourinary malignancies. Urothelial carcinoma is the most common type of bladder cancer, of which approximately 75% of patients present with non-muscle invasive bladder cancer (NMIBC), 20% with muscle invasive bladder cancer (MIBC), and the other 5% with metastatic disease (1) . Despite the high cost of treatment, the clinical prognosis of bladder cancer remains poor. Transurethral resection of bladder tumor (TURBT) is the primary treatment for low-risk NMIBC, and TURBT combined with BCG intravesical  \nFrontiers in Immunology 01 [frontiersin.org](frontiersin.org)  \ninstillation is the gold standard treatment for medium-and highrisk NMIBC, however, 50-7","cbCaiqMIRapW5zRA","https://ap.wps.com/l/cbCaiqMIRapW5zRA","pdf",2463038,15,"English","# Introduction\n# Phenotype and polarization of macrophages","[{\"question\":\"Why are tumor-associated macrophages important in bladder cancer?\",\"answer\":\"TAMs are abundant infiltrating immune cells in the bladder cancer tumor microenvironment. They affect disease development, progression, treatment response, and metastasis through immunomodulatory factors and angiogenesis.\"},{\"question\":\"What is the current clinical situation for advanced bladder cancer?\",\"answer\":\"Even with chemotherapy, immunotherapy, and surgery, overall survival for advanced bladder cancer remains low. Intravesical BCG and other regimens still leave a substantial recurrence risk and some patients progress to muscle-invasive or metastatic disease.\"},{\"question\":\"How do TAMs arise in the bladder cancer tumor microenvironment?\",\"answer\":\"TAMs originate from bone-marrow-derived monocytes recruited by chemokines, and they can also differentiate from tissue-resident macrophages in response to tumor-related and microenvironment injury factors.\"}]","Tumor-associated macrophages in bladder cancer - roles and targeted therapeutic strategies | PDF",1790023923,38,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ae101b0e51edb652720c7ad49950fe4e.webp",983,1389,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8099092acd15d53e512b291841574826.webp",982,1388,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c983a67906230555b599102d418bde81.webp",981,1386,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3fd36458cd4fe5bad9a0d3e3954545aa.webp",980,1385]